Cargando…
Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review
INTRODUCTION: After the results of phase III vaccine studies became available, the leading oncology societies recommended two doses of COVID-19 vaccination to all patients with cancer with no specific recommendation for tumor type and active treatments. However, the data on the COVID-19 vaccine effi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599356/ https://www.ncbi.nlm.nih.gov/pubmed/34804957 http://dx.doi.org/10.3389/fonc.2021.759108 |